These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

71 related articles for article (PubMed ID: 7180548)

  • 41. Isoniazid acetylation phenotyping in Saudi Arabs.
    Matar KM; Mayet AY; Ayoola EA; Bawazir SA; Al-Faleh FZ; Al-Wazzan A
    J Clin Pharm Ther; 2004 Oct; 29(5):443-7. PubMed ID: 15482388
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Cytochrome P450-mediated metabolism in the human gut wall.
    Thelen K; Dressman JB
    J Pharm Pharmacol; 2009 May; 61(5):541-58. PubMed ID: 19405992
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Inhibition of lysyl oxidase by isoniazid and its effect on wound healing.
    Udupa SL
    Indian J Exp Biol; 1995 Apr; 33(4):278-80. PubMed ID: 7558185
    [TBL] [Abstract][Full Text] [Related]  

  • 44. [Studies on mechanism of psycho-neurotic disturbances caused by INAH administration. I. On the relationship between INAH metabolism and convulsion caused by INAH administration].
    Ito S
    Sapporo Igaku Zasshi; 1965; 27(3):127-35. PubMed ID: 5894067
    [No Abstract]   [Full Text] [Related]  

  • 45. Lack of congruence between cysteine dioxygenase activity and S-carboxymethyl-L-cysteine S-oxidation activity in rat cytosol.
    Khan S; Mitchell SC; Steventon GB
    J Pharm Pharmacol; 2004 Aug; 56(8):993-1000. PubMed ID: 15285843
    [TBL] [Abstract][Full Text] [Related]  

  • 46. [Simultaneous study of the induction effect of rifampicin and the phenotype for acetylation of isoniazid in 21 patients with tuberculosis undergoing a combination treatment].
    Chailleux E; Ordronneau J; Le Normand Y; Kergueris MF; Larousse C
    Rev Fr Mal Respir; 1980; 8(3):219-24. PubMed ID: 7187065
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Role of glutathione in nitric oxide-dependent regulation of energy metabolism in rat hepatoma cells.
    Nishikawa M; Sato EF; Kashiba M; Kuroki T; Utsumi K; Inoue M
    Hepatology; 1998 Feb; 27(2):422-6. PubMed ID: 9462640
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Alginate microspheres of isoniazid for oral sustained drug delivery.
    Rastogi R; Sultana Y; Aqil M; Ali A; Kumar S; Chuttani K; Mishra AK
    Int J Pharm; 2007 Apr; 334(1-2):71-7. PubMed ID: 17113732
    [TBL] [Abstract][Full Text] [Related]  

  • 49. The structure of arylamine N-acetyltransferase from Mycobacterium smegmatis--an enzyme which inactivates the anti-tubercular drug, isoniazid.
    Sandy J; Mushtaq A; Kawamura A; Sinclair J; Sim E; Noble M
    J Mol Biol; 2002 May; 318(4):1071-83. PubMed ID: 12054803
    [TBL] [Abstract][Full Text] [Related]  

  • 50. [Ultrastructure of the myenteric plexus in the small and large intestine].
    Ostenda M; Jedrzejewska A
    Patol Pol; 1981; 32(2):243-55. PubMed ID: 7322644
    [No Abstract]   [Full Text] [Related]  

  • 51. Alterations in glutathione homeostasis in mutant Eisai hyperbilirubinemic rats.
    Lu SC; Cai J; Kuhlenkamp J; Sun WM; Takikawa H; Takenaka O; Horie T; Yi J; Kaplowitz N
    Hepatology; 1996 Jul; 24(1):253-8. PubMed ID: 8707271
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Asymmetric intestinal first-pass metabolism causes minimal oral bioavailability of midazolam in cynomolgus monkey.
    Nishimura T; Amano N; Kubo Y; Ono M; Kato Y; Fujita H; Kimura Y; Tsuji A
    Drug Metab Dispos; 2007 Aug; 35(8):1275-84. PubMed ID: 17470527
    [TBL] [Abstract][Full Text] [Related]  

  • 53. [Acetylation phenotype and its clinical significance].
    Orzechowska-Juzwenko K; Milejski P
    Pol Tyg Lek; 1982 Nov; 37(45):1365-7. PubMed ID: 7163093
    [No Abstract]   [Full Text] [Related]  

  • 54. [Metabolism of isoniazid. I. Anthropological aspect].
    De March Ayuela P; Noguera García J
    Rev Clin Esp; 1966 Jul; 102(1):32-41. PubMed ID: 5331589
    [No Abstract]   [Full Text] [Related]  

  • 55. [Intravenous isoniazid (comparative study of its metabolism and that of orally-administered isoniazid)].
    DOYLE JA; FRIGERIO M; DE RAMIREZ MR; ROSSO D
    Sem Med; 1959 Aug; 115():304-8. PubMed ID: 13817931
    [No Abstract]   [Full Text] [Related]  

  • 56. Genetic control of isoniazid metabolism in man.
    EVANS DA; MANLEY KA; McKUSICK VA
    Br Med J; 1960 Aug; 2(5197):485-91. PubMed ID: 13820968
    [No Abstract]   [Full Text] [Related]  

  • 57. [On the significance of isoniazid metabolism as a hereditary metabolic characteristic of normal persons].
    PFAFFENBERG R
    Klin Wochenschr; 1961 Feb; 39():204-5. PubMed ID: 13735125
    [No Abstract]   [Full Text] [Related]  

  • 58. [On the problem of disintegration of phthivazid in the gastrointestinal tract].
    GREBENNIK LI; SMIRNOV GA; GNEVKOVSKAIA TV
    Biull Eksp Biol Med; 1961 Oct; 52():75-7. PubMed ID: 13901367
    [No Abstract]   [Full Text] [Related]  

  • 59. [Effect of cysteine on isoniazid metabolism in rats].
    Lutosławska G
    Acta Pol Pharm; 1982; 39(1-3):173-8. PubMed ID: 7180548
    [No Abstract]   [Full Text] [Related]  

  • 60. [Isoniazid metabolism in the small-intestinal wall of rats].
    Lutosławska G
    Acta Pol Pharm; 1981; 38(6):711-5. PubMed ID: 7348531
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 4.